BMY · Bristol Myers Squibb Co · Documents

May 6

Current report 8-K Events of May 4

Shareholder vote results

May 4

Current report 8-K

Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change

Apr 29

Earnings call

Q1 2021 earnings call

Apr 29

Current report 8-K

Financial results, Regulation FD disclosure

Apr 29

Quarterly report 10-Q FY2021 Q1, ended Mar 31

Quarterly report for FY2021 Q1

Revenue $11.07B ▲ 2.7% Net income $2.02B Diluted EPS $0.89

Apr 19

Proxy statement DEFA14A

Proxy statement

Mar 25

Proxy statement DEF 14A Meeting May 4, 2021

Proxy statement

Mar 25

Proxy statement DEFA14A

Proxy statement

Mar 12

Proxy statement PRE 14A Meeting May 4, 2021

Proxy statement

Mar 4

Current report 8-K Events of Mar 1

Director or officer change, or executive pay

Feb 23

Current report 8-K Events of Feb 19

Other events

Feb 22

Current report 8-K Events of Feb 18

Other events

Feb 10

Current report 8-K

Director or officer change, or executive pay

Feb 10

Annual report 10-K FY2020, ended Dec 31

Annual report for FY2020

Revenue $42.52B ▲ 62.6% Net loss $9.02B Diluted EPS -$3.99

Feb 4

Current report 8-K

Financial results

Feb 4

Current report 8-K

Other events

Feb 4

Earnings call

Q4 2020 earnings call

Feb 2

Current report 8-K

Ended a material agreement

Jan 11

Current report 8-K

Regulation FD disclosure

Jan 4

Current report 8-K Events of Jan 1

Other events

Nov 17

Current report 8-K

Other events

Nov 17

Tender offer SC TO-T/A

Tender offer

Nov 13

Current report 8-K

Entered into a material agreement, New debt or off-balance-sheet obligation, Other events

Nov 6

Current report 8-K Events of Nov 4

Entered into a material agreement, New debt or off-balance-sheet obligation

Nov 5

Current report 8-K

Financial results

Nov 5

Quarterly report 10-Q FY2020 Q3, ended Sep 30

Quarterly report for FY2020 Q3

Revenue $10.54B ▲ 75.5% Net income $1.87B ▲ 38.4% Diluted EPS $0.82 ▼ 1.2%

Nov 5

Earnings call

Q3 2020 earnings call

Nov 4

Tender offer SC TO-T/A

Tender offer

Oct 30

Tender offer SC TO-T/A

Tender offer

Oct 19

Tender offer SC TO-T

Tender offer

Oct 6

Tender offer SC TO-C

Tender offer

Oct 5

Current report 8-K Events of Oct 3

Other events

Oct 5

Tender offer SC TO-C

Tender offer

Aug 20

Current report 8-K Events of Aug 19

Other events

Aug 6

Current report 8-K

Financial results

Aug 6

Quarterly report 10-Q FY2020 Q2, ended Jun 30

Quarterly report for FY2020 Q2

Revenue $10.13B ▲ 61.5% Net loss $85M Diluted EPS -$0.04

Aug 6

Earnings call

Q2 2020 earnings call

Jul 30

Current report 8-K Events of Jul 29

Director or officer change, or executive pay

Jul 16

Current report 8-K

Other events

Jun 16

Current report 8-K

Other events

May 20

Registration statement S-4

Registration statement

May 19

Current report 8-K

Other events

May 7

Current report 8-K

Financial results

May 7

Quarterly report 10-Q FY2020 Q1, ended Mar 31

Quarterly report for FY2020 Q1

Revenue $10.78B ▲ 82.1% Net loss $775M Diluted EPS -$0.34

May 7

Earnings call

Q1 2020 earnings call

Apr 23

Proxy statement DEFA14A

Proxy statement

Apr 14

Current report 8-K

Other events

Apr 14

Proxy statement DEFA14A

Proxy statement

Mar 25

Proxy statement DEF 14A Meeting May 5, 2020

Proxy statement

Mar 25

Current report 8-K

Other events